Thus far in the calendar year 2025, the stock price of GSK Pharma has zoomed 40 per cent, as against 1.8 per cent rise in BSE ...

In a report released today, Jo Walton from UBS maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of ...

GSK PLC closed 25.31% below its 52-week high of £18.24, which the company reached on May 16th.

NOTE: Since the initial appearance of this essay in the 1998 edition of Major Marketing Campaigns Annual, SmithKline Beecham merged with Glaxo to form GlaxoSmithKline plc. The essay continues to refer ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price ...

GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc., a global biopharma company to unite science, technology and talent to get ahead of disease together. The Company is ...

GSK plc, formerly known as GlaxoSmithKline plc, is a British multinational pharmaceutical and biotechnology company headquartered in London. Established in 2000 through the merger of Glaxo ...

GlaxoSmithKline was formerly called ... Norwich Union and CGU plc, and is the 14th largest insurance company in the world. British American Tobacco is the world’s 2nd largest cigarette ...

DUBLIN--(BUSINESS WIRE)--The "Enterprise Tech Ecosystem Series: GSK plc 2024" company profile has been added to ResearchAndMarkets.com's offering. The report provides insights into company's tech ...

GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of GSK plc, a global healthcare company dedicated to leveraging science, technology, and talent to address disease challenges worldwide.